 |
61 Diseases |  |
24 Trials |
|
24 Trials |  |
800 News |  |
| «12...234567891011121314» |
- | Trial initiation date, Trial primary completion date: Gait Analysis in Neurological Disease (clinicaltrials.gov) - Mar 10, 2017
P=N/A, N=60, Recruiting, Sponsor: Beth Israel Deaconess Medical Center
Initiation date: Dec 2015 --> Mar 2016 | Trial primary completion date: Oct 2017 --> Oct 2018
- ||| ODM-104 / Orion Corp
New P1 trial: COMDOS1: Dose-finding Pharmacokinetic Study in Healthy Males (clinicaltrials.gov) - Feb 16, 2017
P1, N=56, Not yet recruiting, Sponsor: Orion Corporation, Orion Pharma
- Ergonex (ergotamine/caffeine) / AC Farma
Phase classification, Enrollment change: Treatment of Orthostatic Hypotension in Autonomic Failure (clinicaltrials.gov) - Jan 18, 2017
P1, N=389, Completed, Sponsor: Vanderbilt University
Initiation date: Dec 2015 --> Mar 2016 | Trial primary completion date: Oct 2017 --> Oct 2018 Phase classification: P3 --> P1 | N=80 --> 389
- | carbidopa/levodopa / Generic mfg.
New P2 trial: Dose Ranging Study of Carbidopa-levodopa (clinicaltrials.gov) - Jan 18, 2017
P2, N=52, Not yet recruiting, Sponsor: Snyder, Robert W., M.D., Ph.D., P.C.
- | Ergonex (ergotamine/caffeine) / AC Farma
Trial completion, Enrollment change, Trial primary completion date: Treatment of Orthostatic Hypotension in Autonomic Failure (clinicaltrials.gov) - Jan 17, 2017
P3, N=80, Completed, Sponsor: Vanderbilt University
Phase classification: P3 --> P1 | N=80 --> 389 Recruiting --> Completed | N=500 --> 80 | Trial primary completion date: Apr 2017 --> Jan 2017
- carbidopa/levodopa / Generic mfg.
Biomarker, Trial initiation date, Trial primary completion date, Metastases: A Safety and Efficacy Study of Carbidopa-levodopa in Patients With Macular Degeneration (clinicaltrials.gov) - Jan 17, 2017
P2, N=104, Not yet recruiting, Sponsor: Snyder, Robert W., M.D., Ph.D., P.C.
Recruiting --> Completed | N=500 --> 80 | Trial primary completion date: Apr 2017 --> Jan 2017 Initiation date: Sep 2016 --> Sep 2018 | Trial primary completion date: Dec 2017 --> Dec 2019
- | carbidopa/levodopa / Generic mfg.
New P2 trial: Carbidopa-levodopa in Neovascular AMD (clinicaltrials.gov) - Jan 17, 2017
P2, N=52, Not yet recruiting, Sponsor: Snyder, Robert W., M.D., Ph.D., P.C.
- Trial primary completion date: Gait Analysis in Neurological Disease (clinicaltrials.gov) - Jan 15, 2017
P=N/A, N=60, Recruiting, Sponsor: Beth Israel Deaconess Medical Center
Initiation date: Sep 2016 --> Sep 2018 | Trial primary completion date: Dec 2017 --> Dec 2019 Trial primary completion date: Jan 2017 --> Oct 2017
- New trial: Gait Analysis in Neurological Disease (clinicaltrials.gov) - Jan 11, 2017
P=N/A, N=60, Recruiting, Sponsor: Beth Israel Deaconess Medical Center
- | Inbrija (levodopa inhalation powder) / Acorda
Trial completion: A Study to Compare Two Dose Strengths of CVT-301 (Levodopa Inhalation Powder) With an Oral Dose of Sinemet® (Carbidopa-levodopa) Tablets (clinicaltrials.gov) - Oct 11, 2016
P1, N=24, Completed, Sponsor: Acorda Therapeutics
Trial primary completion date: Jan 2017 --> Oct 2017 Active, not recruiting --> Completed
- carbidopa/levodopa / Generic mfg., amphetamine / Generic mfg.
Trial completion, Trial primary completion date: Neurobiological Principles Applied to the Rehabilitation of Stroke Patients (clinicaltrials.gov) - Oct 3, 2016
P=N/A, N=26, Completed, Sponsor: Emory University
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Dec 2016 --> Sep 2016
- Enrollment change, Trial primary completion date: Inflammation-related Alterations in Neurocircuitry: Reversal With Levodopa (clinicaltrials.gov) - Sep 29, 2016
P4, N=76, Recruiting, Sponsor: Emory University
Active, not recruiting --> Completed | Trial primary completion date: Dec 2016 --> Sep 2016 N=13 --> 76 | Trial primary completion date: Aug 2016 --> Jun 2020
- | carbidopa/levodopa / Generic mfg.
Biomarker, New P2 trial, Metastases: A Safety and Efficacy Study of Carbidopa-levodopa in Patients With Macular Degeneration (clinicaltrials.gov) - Aug 18, 2016
P2, N=104, Not yet recruiting, Sponsor: Snyder, Robert W., M.D., Ph.D., P.C.
- Inbrija (levodopa inhalation powder) / Acorda
Enrollment closed: A Study to Compare Two Dose Strengths of CVT-301 (Levodopa Inhalation Powder) With an Oral Dose of Sinemet® (Carbidopa-levodopa) Tablets (clinicaltrials.gov) - Aug 15, 2016
P1, N=24, Active, not recruiting, Sponsor: Acorda Therapeutics
N=13 --> 76 | Trial primary completion date: Aug 2016 --> Jun 2020 Recruiting --> Active, not recruiting
- carbidopa/levodopa / Generic mfg.
New P2 trial: Studying a Potential Protective Effect of L-Dopa on Retinitis Pigmentosa (clinicaltrials.gov) - Jul 19, 2016
P2, N=50, Recruiting, Sponsor: Beirut Eye Specialist Hospital
- | Inbrija (levodopa inhalation powder) / Acorda
New P1 trial: A Study to Compare Two Dose Strengths of CVT-301 (Levodopa Inhalation Powder) With an Oral Dose of Sinemet® (Carbidopa-levodopa) Tablets (clinicaltrials.gov) - Jun 24, 2016
P1, N=24, Recruiting, Sponsor: Acorda Therapeutics
- carbidopa/levodopa / Generic mfg., naproxen ER / Generic mfg., naproxen / Generic mfg.
Trial primary completion date: Effect of L-dopa In Subacute Back Pain Population (clinicaltrials.gov) - Jun 19, 2016
P4, N=150, Recruiting, Sponsor: Northwestern University
Recruiting --> Active, not recruiting Trial primary completion date: Jun 2016 --> Dec 2016
- ||| carbidopa/levodopa / Generic mfg.
Clinical: Global REsponsE During iNFusIon of a gEl With LevoDopa/Carbidopa (clinicaltrials.gov) - Jun 19, 2016
P=N/A, N=148, Completed, Sponsor: AbbVie (prior sponsor, Abbott)
Trial primary completion date: Jun 2016 --> Dec 2016 Active, not recruiting --> Completed
- carbidopa/levodopa / Generic mfg., amphetamine / Generic mfg.
Enrollment closed: Neurobiological Principles Applied to the Rehabilitation of Stroke Patients (clinicaltrials.gov) - May 20, 2016
P=N/A, N=26, Active, not recruiting, Sponsor: Emory University
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- Trial primary completion date: Inflammation-related Alterations in Neurocircuitry: Reversal With Levodopa (clinicaltrials.gov) - May 18, 2016
P4, N=13, Recruiting, Sponsor: Emory University
Recruiting --> Active, not recruiting Trial primary completion date: May 2016 --> Aug 2016
- | carbidopa/levodopa / Generic mfg.
New P1 trial: Pharmacokinetic-pharmacodynamic Interaction Between BIA 3-202 and Levodopa/Carbidopa (clinicaltrials.gov) - May 18, 2016
P1, N=16, Completed, Sponsor: Bial - Portela C S.A.
- DopaFuse (levodopa/carbidopa continuous-release) / SynAgile
New P2a trial, Metastases: Intermittent Oral Administration vs. Semi-continuous Intra-oral Administration of Levodopa/Carbidopa in Fluctuating Parkinsonian Patients (clinicaltrials.gov) - May 5, 2016
P2a, N=18, Completed, Sponsor: IRCCS San Raffaele
- | carbidopa/levodopa / Generic mfg.
New P1 trial: Pharmacokinetic-Pharmacodynamic Interaction Between Four Different Single Doses of BIA 3-202 and a Single Dose of Levodopa/Carbidopa (100/25 mg) (clinicaltrials.gov) - May 5, 2016
P1, N=19, Completed, Sponsor: Bial - Portela C S.A.
- Ergonex (ergotamine/caffeine) / AC Farma
Trial primary completion date: Treatment of Orthostatic Hypotension in Autonomic Failure (clinicaltrials.gov) - Apr 28, 2016
P3, N=500, Recruiting, Sponsor: Vanderbilt University
Trial primary completion date: May 2016 --> Aug 2016 Trial primary completion date: Apr 2016 --> Apr 2017
- carbidopa/levodopa / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: Antipsychotic Augmentation With L-Dopa (clinicaltrials.gov) - Mar 15, 2016
P2, N=13, Completed, Sponsor: Centre for Addiction and Mental Health
Trial primary completion date: Apr 2016 --> Apr 2017 Recruiting --> Completed | N=24 --> 13 | Trial primary completion date: Sep 2016 --> Dec 2015
- carbidopa/levodopa / Generic mfg.
Trial primary completion date: Combining Robotic-Assisted Therapy and Pharmacotherapy in Post-Stroke Rehabilitation (clinicaltrials.gov) - Feb 23, 2016
P4, N=40, Recruiting, Sponsor: Ross D. Zafonte, MD
Recruiting --> Completed | N=24 --> 13 | Trial primary completion date: Sep 2016 --> Dec 2015 Trial primary completion date: Mar 2016 --> Mar 2017
- citalopram / Generic mfg., carbidopa/levodopa / Generic mfg.
Trial primary completion date: SELEIS: Effect of Serotonin and Levodopa in Ischemic Stroke (clinicaltrials.gov) - Feb 22, 2016
P4, N=240, Recruiting, Sponsor: Hospital de Granollers
Trial primary completion date: Mar 2016 --> Mar 2017 Trial primary completion date: Dec 2015 --> Dec 2016
- Trial primary completion date: Substance Abuse Pre-Treatment Screening Study (clinicaltrials.gov) - Dec 30, 2015
P=N/A, N=7500, Recruiting, Sponsor: The University of Texas Health Science Center, Houston
Trial primary completion date: Dec 2015 --> Dec 2016 Trial primary completion date: Jun 2013 --> Jun 2016
- Accordion Pill carbidopa/levodopa CR (carbidopa/levodopa CR) / Jazz, Indaptus Therap
Enrollment change, Trial withdrawal: Gastric Retentive Carbidopa/ Levodopa in Parkinson's Patients; a One Year, Open Label, Safety Extension Study (clinicaltrials.gov) - Nov 15, 2015
P2, N=0, Withdrawn, Sponsor: Intec Pharma Ltd.
Trial primary completion date: Jun 2013 --> Jun 2016 N=36 --> 0 | Suspended --> Withdrawn
- carbidopa/levodopa / Generic mfg.
New trial: NORAPARK: Common Noradrenergic Mechanisms in Parkinson´s Disease and L-DOPA Induced Dyskinesia (clinicaltrials.gov) - Oct 23, 2015
P=N/A, N=45, Recruiting, Sponsor: Aarhus University Hospital
- carbidopa/levodopa / Generic mfg.
Trial primary completion date: Antipsychotic Augmentation With L-Dopa (clinicaltrials.gov) - Sep 25, 2015
P2, N=24, Recruiting, Sponsor: Centre for Addiction and Mental Health
N=36 --> 0 | Suspended --> Withdrawn Trial primary completion date: Sep 2015 --> Sep 2016
- carbidopa/levodopa / Generic mfg.
Enrollment open: Combining Robotic-Assisted Therapy and Pharmacotherapy in Post-Stroke Rehabilitation (clinicaltrials.gov) - Sep 3, 2015
P4, N=40, Recruiting, Sponsor: Ross D. Zafonte, MD
Trial primary completion date: Sep 2015 --> Sep 2016 Not yet recruiting --> Recruiting
- carbidopa/levodopa / Generic mfg.
Trial completion, Trial primary completion date: Study to Assess Safety, Tolerability and MTD of a Central Pattern Generator-activating Tritherapy (SPINALON) in Patients With Chronic Spinal Cord Injury (clinicaltrials.gov) - Aug 21, 2015
P1/2, N=50, Completed, Sponsor: Nordic Life Science Pipeline Inc.
Not yet recruiting --> Recruiting Recruiting --> Completed | Trial primary completion date: Apr 2015 --> Aug 2015
- New P4 trial: Inflammation-related Alterations in Neurocircuitry: Reversal With Levodopa (clinicaltrials.gov) - Jul 31, 2015
P4, N=13, Recruiting, Sponsor: Emory University
- carbidopa/levodopa / Generic mfg.
Trial primary completion date: A Trial of Levodopa in Angelman Syndrome (clinicaltrials.gov) - Jul 21, 2015
P2/3, N=73, Completed, Sponsor: Wen-Hann Tan
Recruiting --> Completed | Trial primary completion date: Apr 2015 --> Aug 2015 Trial primary completion date: Nov 2014 --> Jul 2015
- carbidopa/levodopa / Generic mfg.
New P1 trial: A Single Period Investigation to Assess the Tolerability of Healthy Subjects to Oral Sinemet (clinicaltrials.gov) - Jul 1, 2015
P1, N=6, Completed, Sponsor: NeuroDerm Ltd.
- Ergonex (ergotamine/caffeine) / AC Farma
Trial primary completion date: Treatment of Orthostatic Hypotension in Autonomic Failure (clinicaltrials.gov) - Jun 11, 2015
P3, N=500, Recruiting, Sponsor: Vanderbilt University
Trial primary completion date: Nov 2014 --> Jul 2015 Trial primary completion date: May 2015 --> Apr 2016
- carbidopa/levodopa / Generic mfg., amphetamine / Generic mfg.
Trial primary completion date: Neurobiological Principles Applied to the Rehabilitation of Stroke Patients (clinicaltrials.gov) - Apr 17, 2015
P=N/A, N=26, Recruiting, Sponsor: Emory University
Trial primary completion date: May 2015 --> Apr 2016 Trial primary completion date: Dec 2015 --> Dec 2016
- | citalopram / Generic mfg., carbidopa/levodopa / Generic mfg.
New P4 trial: SELEIS: Effect of Serotonin and Levodopa in Ischemic Stroke (clinicaltrials.gov) - Mar 12, 2015
P4, N=240, Recruiting, Sponsor: Hospital de Granollers
- |||| carbidopa/levodopa / Generic mfg., naproxen ER / Generic mfg., naproxen / Generic mfg.
Enrollment open, Trial initiation date: Effect of L-dopa In Subacute Back Pain Population (clinicaltrials.gov) - Mar 2, 2015
P4, N=150, Recruiting, Sponsor: Northwestern University
Trial primary completion date: Dec 2015 --> Dec 2016 Not yet recruiting --> Recruiting | Initiation date: Oct 2014 --> Feb 2015
- carbidopa/levodopa / Generic mfg.
Trial primary completion date: Combining Robotic-Assisted Therapy and Pharmacotherapy in Post-Stroke Rehabilitation (clinicaltrials.gov) - Feb 26, 2015
P4, N=40, Not yet recruiting, Sponsor: Ross D. Zafonte, MD
Not yet recruiting --> Recruiting | Initiation date: Oct 2014 --> Feb 2015 Trial primary completion date: Dec 2015 --> Mar 2016
- | ODM-104 / Orion Corp
Trial completion, Enrollment change: NOCOF: Pharmacokinetic Study in Healthy Males (clinicaltrials.gov) - Feb 19, 2015
P1, N=20, Completed, Sponsor: Orion Corporation, Orion Pharma
Trial primary completion date: Dec 2015 --> Mar 2016 Recruiting --> Completed | N=15 --> 20
- | carbidopa/levodopa / Generic mfg.
Trial completion: ATS17: Levodopa for the Treatment of Residual Amblyopia (clinicaltrials.gov) - Feb 13, 2015
P3, N=139, Completed, Sponsor: Jaeb Center for Health Research
Recruiting --> Completed | N=15 --> 20 Active, not recruiting --> Completed
- | carbidopa/levodopa / Generic mfg.
Trial completion, Enrollment change: A Trial of Levodopa in Angelman Syndrome (clinicaltrials.gov) - Feb 3, 2015
P2/3, N=73, Completed, Sponsor: Wen-Hann Tan
Active, not recruiting --> Completed Active, not recruiting --> Completed | N=100 --> 73
- carbidopa/levodopa / Generic mfg.
New P4 trial: Combining Robotic-Assisted Therapy and Pharmacotherapy in Post-Stroke Rehabilitation (clinicaltrials.gov) - Jan 28, 2015
P4, N=40, Not yet recruiting, Sponsor: Ross D. Zafonte, MD
- | ODM-104 / Orion Corp
New P1 trial: NOCOF: Pharmacokinetic Study in Healthy Males (clinicaltrials.gov) - Dec 10, 2014
P1, N=15, Recruiting, Sponsor: Orion Corporation, Orion Pharma
- carbidopa/levodopa / Generic mfg., amphetamine / Generic mfg.
Trial primary completion date: Neurobiological Principles Applied to the Rehabilitation of Stroke Patients (clinicaltrials.gov) - Nov 19, 2014
P=N/A, N=26, Recruiting, Sponsor: Emory University
Active, not recruiting --> Completed | N=100 --> 73 Trial primary completion date: Dec 2014 --> Dec 2015
- || carbidopa/levodopa / Generic mfg.
Clinical: Global REsponsE During iNFusIon of a gEl With LevoDopa/Carbidopa (clinicaltrials.gov) - Nov 17, 2014
P=N/A, N=150, Active, not recruiting, Sponsor: AbbVie (prior sponsor, Abbott)
Trial primary completion date: Dec 2014 --> Dec 2015 Trial primary completion date: Sep 2015 --> Jun 2016
- carbidopa/levodopa / Generic mfg., naproxen ER / Generic mfg., naproxen / Generic mfg.
Enrollment change, Trial withdrawal: Efficacy of Co-administration of an NSAID With a Dopamine Agonist In Healthy Subjects (clinicaltrials.gov) - Oct 10, 2014
P2, N=0, Withdrawn, Sponsor: Northwestern University
Trial primary completion date: Sep 2015 --> Jun 2016 N=40 --> 0 | Not yet recruiting --> Withdrawn
- carbidopa/levodopa / Generic mfg.
Trial primary completion date: Study to Assess Safety, Tolerability and MTD of a Central Pattern Generator-activating Tritherapy (SPINALON) in Patients With Chronic Spinal Cord Injury (clinicaltrials.gov) - Sep 29, 2014
P1/2, N=50, Recruiting, Sponsor: Nordic Life Science Pipeline Inc.
N=40 --> 0 | Not yet recruiting --> Withdrawn Trial primary completion date: Jul 2014 --> Apr 2015